Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns?
Jelske W van der Burg1, Elizabeth N Allred, Thomas F McElrath
1Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, United States; Department of Health Sciences and the EMGO Institute for Health and Care Research, VU University Amsterdam, Amsterdam, The Netherlands.
Insights
Maternal obesity may increase inflammation in very preterm newborns delivered for medical reasons. This effect was not observed in spontaneous deliveries, suggesting competing inflammatory factors in those cases.
Area of Science:
- Neonatal research
- Maternal-fetal medicine
- Inflammation and immunology
Background:
- Offspring of obese women face higher systemic inflammation risks.
- Blood inflammatory protein levels in preterm infants of obese mothers remain underreported.
Purpose of the Study:
- Compare inflammatory protein concentrations in preterm infants based on maternal pre-pregnancy BMI (overweight/obese vs. lower BMI).
- Investigate the influence of delivery indication (spontaneous vs. maternal/fetal) on these associations.
Main Methods:
- Prospective cohort study of 939 infants born before 28 weeks gestation.
- Measured 25 inflammation-related proteins in blood samples collected on postnatal days 1, 7, and 14.
- Analyzed data separately for spontaneous and medically indicated deliveries.
Main Results:
- Maternal BMI was not linked to elevated proteins in infants from spontaneous deliveries.
- Infants of overweight or obese mothers were more likely to have elevated inflammation proteins if delivered for maternal (e.g., preeclampsia) or fetal indications.
Conclusions:
- Maternal pre-pregnancy overweight and obesity may promote a pro-inflammatory state in very preterm neonates delivered for medical reasons.
- The absence of this association in spontaneous deliveries might be due to competing inflammatory risks.
Background:
The offspring of obese women are at increased risk for systemic inflammation. Blood concentrations of inflammatory proteins in preterm newborns of obese women have not been reported.
Aim:
To compare blood concentrations in the highest quartile for gestational age of inflammatory proteins and day of blood specimen collection on two days at least one week apart of newborns of overweight (i.e., BMI 25-29) and obese women (i.e., BMI ≥ 30) with newborns of women with lower BMIs. Because deliveries for spontaneous indications are more likely than those for other indications to be associated with inflammation, we evaluated spontaneous indication deliveries separately from maternal or fetal indications.
Study Design:
Prospective cohort study.
Subjects And Outcome Measures:
We measured from 939 children born before the 28th week of gestation 25 inflammation-related proteins in blood obtained on postnatal day 1 (range 1-3), day 7 (range 5-8) and day 14 (range 12-15).
Results:
Among infants delivered for spontaneous indications, maternal BMI was not related to elevated concentrations of any protein. Among infants delivered for maternal (i.e., preeclampsia) or fetal indications, those whose mother was overweight or obese were more likely than others to have elevated concentrations of inflammation proteins.
Conclusions:
Maternal pre-pregnancy overweight and obesity appear to contribute to a pro-inflammatory state in very preterm newborns delivered for maternal or fetal indications. Our failure to see a similar pattern among newborns delivered for spontaneous indications, which often have inflammatory characteristics, might reflect competing risks.
Related Concept Videos
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational
Development of the Oral Microbiota
Inflammatory Bowel Disease III: Crohn's Disease

